110 related articles for article (PubMed ID: 14588117)
1. Spinal cord injury induces lesional expression of the proinflammatory and antiangiogenic cytokine EMAP II.
Mueller CA; Schluesener HJ; Conrad S; Meyermann R; Schwab JM
J Neurotrauma; 2003 Oct; 20(10):1007-15. PubMed ID: 14588117
[TBL] [Abstract][Full Text] [Related]
2. Lesional expression of a proinflammatory and antiangiogenic cytokine EMAP II confined to endothelium and microglia/macrophages during secondary damage following experimental traumatic brain injury.
Mueller CA; Schluesener HJ; Conrad S; Meyermann R; Schwab JM
J Neuroimmunol; 2003 Feb; 135(1-2):1-9. PubMed ID: 12576219
[TBL] [Abstract][Full Text] [Related]
3. Spinal cord injury-induced expression of the antiangiogenic endostatin/collagen XVIII in areas of vascular remodelling.
Mueller CA; Conrad S; Schluesener HJ; Pietsch T; Schwab JM
J Neurosurg Spine; 2007 Aug; 7(2):205-14. PubMed ID: 17688061
[TBL] [Abstract][Full Text] [Related]
4. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
[TBL] [Abstract][Full Text] [Related]
5. FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury.
Zhang Z; Zhang Z; Fauser U; Artelt M; Burnet M; Schluesener HJ
J Cell Mol Med; 2007; 11(2):307-14. PubMed ID: 17488479
[TBL] [Abstract][Full Text] [Related]
6. Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes.
van Horssen R; Eggermont AM; ten Hagen TL
Cytokine Growth Factor Rev; 2006 Oct; 17(5):339-48. PubMed ID: 16945568
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of the proinflammatory cytokine endothelial-monocyte-activating polypeptide II in ramified microglial cells in brains of Borna virus infected Lewis rats.
Mueller CA; Richt JA; Meyermann R; Deininger M; Schluesener H
Neurosci Lett; 2003 Mar; 339(3):215-8. PubMed ID: 12633891
[TBL] [Abstract][Full Text] [Related]
8. Effects of autoantigen and dexamethasone treatment on expression of endothelial-monocyte activating polypeptide II and allograft-inflammatory factor-1 by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis.
Schluesener HJ; Seid K; Meyermann R
Acta Neuropathol; 1999 Feb; 97(2):119-26. PubMed ID: 9928822
[TBL] [Abstract][Full Text] [Related]
9. Expression of endothelial monocyte-activating polypeptide II in the rat dental follicle and its potential role in tooth eruption.
Liu D; Wise GE
Eur J Oral Sci; 2008 Aug; 116(4):334-40. PubMed ID: 18705801
[TBL] [Abstract][Full Text] [Related]
10. Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury.
Schwab JM; Brechtel K; Nguyen TD; Schluesener HJ
J Neuroimmunol; 2000 Nov; 111(1-2):122-30. PubMed ID: 11063829
[TBL] [Abstract][Full Text] [Related]
11. Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells.
Schluesener HJ; Seid K; Zhao Y; Meyermann R
Glia; 1997 Aug; 20(4):365-72. PubMed ID: 9262239
[TBL] [Abstract][Full Text] [Related]
12. Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells.
Tandle AT; Mazzanti C; Alexander HR; Roberts DD; Libutti SK
Cytokine; 2005 Jun; 30(6):347-58. PubMed ID: 15935955
[TBL] [Abstract][Full Text] [Related]
13. Expression of EMAP-II by activated monocytes/microglial cells in different regions of the rat hippocampus after trimethyltin-induced brain damage.
Brabeck C; Michetti F; Geloso MC; Corvino V; Goezalan F; Meyermann R; Schluesener HJ
Exp Neurol; 2002 Sep; 177(1):341-6. PubMed ID: 12429238
[TBL] [Abstract][Full Text] [Related]
14. Prolonged lesional expression of RhoA and RhoB following spinal cord injury.
Conrad S; Schluesener HJ; Trautmann K; Joannin N; Meyermann R; Schwab JM
J Comp Neurol; 2005 Jun; 487(2):166-75. PubMed ID: 15880494
[TBL] [Abstract][Full Text] [Related]
15. EMAP-II downregulation contributes to the beneficial effects of rapamycin after vascular injury.
Nührenberg TG; Langwieser N; Schwarz JB; Hou Y; Frank P; Sorge F; Matschurat S; Seidl S; Kastrati A; Schömig A; Clauss MA; Zohlnhöfer D
Cardiovasc Res; 2008 Feb; 77(3):580-9. PubMed ID: 18029408
[TBL] [Abstract][Full Text] [Related]
16. AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats.
Schwab JM; Frei E; Klusman I; Schnell L; Schwab ME; Schluesener HJ
J Neuroimmunol; 2001 Oct; 119(2):214-22. PubMed ID: 11585624
[TBL] [Abstract][Full Text] [Related]
17. Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.
Murray JC; Heng YM; Symonds P; Rice K; Ward W; Huggins M; Todd I; Robins RA
J Leukoc Biol; 2004 May; 75(5):772-6. PubMed ID: 14982944
[TBL] [Abstract][Full Text] [Related]
18. Spinal cord injury induces early and persistent lesional P2X4 receptor expression.
Schwab JM; Guo L; Schluesener HJ
J Neuroimmunol; 2005 Jun; 163(1-2):185-9. PubMed ID: 15885321
[TBL] [Abstract][Full Text] [Related]
19. In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-II.
Schwarz RE; Schwarz MA
J Surg Res; 2004 Jul; 120(1):64-72. PubMed ID: 15172191
[TBL] [Abstract][Full Text] [Related]
20. Spinal cord injury-induced expression of the immune-regulatory chemokine interleukin-16 caused by activated microglia/macrophages and CD8+ cells.
Mueller CA; Schluesener HJ; Conrad S; Pietsch T; Schwab JM
J Neurosurg Spine; 2006 Mar; 4(3):233-40. PubMed ID: 16572623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
